DXB 7.46% 36.0¢ dimerix limited

"they just need the phase 3 interim read-out to demonstrate that...

  1. 429 Posts.
    lightbulb Created with Sketch. 211
    "they just need the phase 3 interim read-out to demonstrate that the efficacy is also statistically significant"
    you don't understand how futility analysis works. Read this:
    http://onbiostatistics.blogspot.com/2012/03/futility-analysis-in-clinical-trials.html
    even if the independent committee says it is OK to proceed with rest of the trial in a few weeks, that does not mean the results seen are at all "statistically significant" (as in p less than 0.05 as the accepted benchmark). it does not even mean the final results in a few years will be successful.

    gotta love this site, some of the strange beliefs and myths you read- just love coming here. there's one bozo in one of the threads claiming that the asset can be commercialized after a successful futility analysis in a few weeks. and now we have some people looking at how somebody smiles on YouTube video as clues to whether there's a deal- just BRILLIANT.

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
0.025(7.46%)
Mkt cap ! $197.8M
Open High Low Value Volume
34.0¢ 36.3¢ 33.5¢ $3.801M 10.73M

Buyers (Bids)

No. Vol. Price($)
1 20000 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 378856 6
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
36.0¢
  Change
0.025 ( 7.33 %)
Open High Low Volume
33.5¢ 36.5¢ 33.5¢ 5557634
Last updated 15.58pm 03/05/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.